PREZIOSA, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 589
NA - Nord America 522
AS - Asia 160
SA - Sud America 18
AF - Africa 14
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.310
Nazione #
US - Stati Uniti d'America 513
SE - Svezia 334
IT - Italia 117
CN - Cina 62
DE - Germania 45
FI - Finlandia 24
IN - India 22
IR - Iran 19
IE - Irlanda 15
TR - Turchia 12
EG - Egitto 11
SG - Singapore 10
BE - Belgio 9
PL - Polonia 8
CA - Canada 7
ES - Italia 7
JP - Giappone 7
SA - Arabia Saudita 7
FR - Francia 6
HK - Hong Kong 6
PT - Portogallo 6
CL - Cile 5
GB - Regno Unito 5
NO - Norvegia 5
PY - Paraguay 5
AR - Argentina 4
CY - Cipro 4
KR - Corea 4
NL - Olanda 4
AU - Australia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
NG - Nigeria 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
EU - Europa 2
MX - Messico 2
NZ - Nuova Zelanda 2
BD - Bangladesh 1
BR - Brasile 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 1.310
Città #
Princeton 97
Lawrence 96
Ashburn 83
Shanghai 49
New York 48
Milan 44
Rome 25
Helsinki 22
Radebeul 15
Dublin 14
Los Angeles 10
Washington 10
Chennai 9
Ankara 7
Brussels 7
Tehran 7
Düsseldorf 6
Giza 6
Vänersborg 6
Ahmedabad 5
Asunción 5
Oslo 5
Seattle 5
Cairo 4
Istanbul 4
Krakow 4
Marostica 4
Naples 4
Philadelphia 4
Poznan 4
Rio Mayo 4
Riyadh 4
Berlin 3
Città di Castello 3
Dammam 3
Dongguan 3
Hanover 3
Lagos 3
Missaglia 3
New Taipei 3
Pittsburgh 3
Pune 3
Regina 3
Santiago 3
Stockholm 3
Tokyo 3
Tranemo 3
Abu Dhabi 2
Acton 2
Barwāni 2
Boardman 2
Bogotá 2
Calgary 2
Canterbury 2
Carmel 2
Castellammare di Stabia 2
Chandler 2
Chillan 2
Chongqing 2
Chuo 2
Cleveland 2
Dresden 2
Ferrara 2
Foresto Sparso 2
Hepstedt 2
Hok 2
Hong Kong 2
Lisbon 2
Madison 2
Madrid 2
Melbourne 2
Mexico City 2
Milwaukee 2
Mountain View 2
Munich 2
Nuremberg 2
Paris 2
Prague 2
Reggio Emilia 2
Rotterdam 2
Sassuolo 2
Segovia 2
Sejong 2
Toronto 2
Vigo 2
Vila Nova de Gaia 2
Vilvoorde 2
Wellington 2
Woburn 2
Yuseong-gu 2
Amsterdam 1
Ancona 1
Andover 1
Avio 1
Bari 1
Besano 1
Borås 1
Brest 1
Brighton 1
Bursa 1
Totale 758
Nome #
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 112
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 51
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 40
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 26
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 26
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 25
Functional and structural MRI correlates of executive functions in multiple sclerosis 24
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 23
Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR Study 22
Diagnosis of Progressive Multiple Sclerosis from the Imaging Perspective: A Review 22
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 21
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis 21
Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression 18
Association between pathological and MRI findings in multiple sclerosis 17
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis 16
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study 16
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 16
In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI 16
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines 15
Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study 15
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring 15
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 15
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? 15
Central vein sign and iron rim in multiple sclerosis: ready for clinical use? 15
Effects on cognition of DMTs in multiple sclerosis: moving beyond the prevention of inflammatory activity 15
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study 14
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives 14
Action observation training promotes motor improvement and modulates functional network dynamic connectivity in multiple sclerosis 14
COVID-19 will change MS care forever – No 14
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 14
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 14
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis 14
A demyelinating disorder characterized by repeated episodes of optic neuritis and brainstem dysfuntions in a girl with anti-MOG positivity 13
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 13
Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex 13
Imaging correlates of hand motor performance in multiple sclerosis: A multiparametric structural and functional MRI study 13
Quantitative MRI adds to neuropsychiatric lupus diagnostics 13
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 12
Emerging Perspectives on MRI Application in Multiple Sclerosis: Moving from Pathophysiology to Clinical Practice 12
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective 12
What role should spinal cord MRI take in the future of multiple sclerosis surveillance? 12
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study 12
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis 12
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients 11
Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex 11
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 11
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 11
Brain reserve against physical disability progression over five years in multiple sclerosis 11
Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis 11
Action observation training modifies brain gray matter structure in healthy adult individuals 11
Brain mapping in multiple sclerosis: Lessons learned about the human brain 11
A semiautomatic method for multiple sclerosis lesion segmentation on dual-echo MR imaging: application in a multicenter context 11
Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study 11
Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis 11
Measurement of white matter fiber-bundle cross-section in multiple sclerosis using diffusion-weighted imaging 11
Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis 11
COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience 11
MRI of Transcallosal White Matter Helps to Predict Motor Impairment in Multiple Sclerosis 11
Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis 10
MRI predicts cognitive training effects in multiple sclerosis 10
The role of DTI in multiple sclerosis and other demyelinating conditions 10
The current role of MRI in differentiating multiple sclerosis from its imaging mimics 10
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 10
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis 10
Identifying Progression in Multiple Sclerosis: New Perspectives 10
Effect of cognitive reserve on structural and functional MRI measures in healthy subjects: a multiparametric assessment 10
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis? 10
Unraveling the substrates of cognitive impairment in multiple sclerosis: A multiparametric structural and functional magnetic resonance imaging study 10
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 10
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 9
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion 9
Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients 9
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis. 9
Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: a case report 9
Il ruolo della risonanza magnetica nel monitoraggio clinico e della risposta terapeutica 9
DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS 9
Microstructural MR Imaging Techniques in Multiple Sclerosis 9
Two-year regional grey and white matter volume changes with natalizumab and fingolimod 9
Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study 9
Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria 9
Multiple sclerosis 9
Functional and structural plasticity following action observation training in multiple sclerosis 9
Lifespan normative data on rates of brain volume changes 9
Fatigue in multiple sclerosis patients with different clinical phenotypes: a clinical and mri study 9
Effects of Fingolimod and Natalizumab on Brain T1-/T2-Weighted and Magnetization Transfer Ratios: a 2-Year Study 9
Effects of Natalizumab and Fingolimod on Clinica, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis 9
Can post-mortem MRI be used as a proxy for in vivo? A case study 8
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis 8
Multiple sclerosis 8
Gray matter damage predicts the accumulation of disability 13 years later in MS. 8
Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability 8
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection 8
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 7
Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion (Journal of Neurology, (2022), 269, 10, (5382-5394), 10.1007/s00415-022-11193-w) 7
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 7
Application of DIR and DT MRI to quantify focal and diffuse cortical damage in MS. 7
Multiple sclerosis and related disorders 7
Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. 7
Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood 7
Structural and functional brain connectomes in patients with systemic lupus erythematosus 7
Totale 1.384
Categoria #
all - tutte 19.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/202019 6 0 0 4 2 0 1 0 5 1 0 0
2020/202151 0 0 12 2 1 16 4 1 7 2 5 1
2021/2022130 1 4 5 40 2 10 11 19 15 7 9 7
2022/2023737 225 116 57 8 21 79 25 42 66 31 20 47
2023/2024579 32 46 52 111 65 81 59 68 9 53 3 0
Totale 1.555